LOCUS       1TFX_A                   223 aa            linear   MAM 31-OCT-2024
DEFINITION  Chain A, TRYPSIN.
ACCESSION   1TFX_A
VERSION     1TFX_A
DBSOURCE    pdb: molecule 1TFX, chain A, release Oct 30, 2024;
            deposition: Jan 21, 1997;
            class: COMPLEX (SERINE PROTEASE/INHIBITOR);
            source: Mmdb_id: 7140, Pdb_id 1: 1TFX;
            Exp. method: X-ray Diffraction.
KEYWORDS    .
SOURCE      Sus scrofa (pig)
  ORGANISM  Sus scrofa
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Laurasiatheria; Artiodactyla; Suina; Suidae;
            Sus.
REFERENCE   1  (residues 1 to 223)
  AUTHORS   Padmanabhan,K., Padmanabhan,K.P., Tulinsky,A., Park,C.H., Bode,W.,
            Huber,R., Blankenship,D.T., Cardin,A.D. and Kisiel,W.
  TITLE     Structure of Human Des(1-45) Factor Xa at 2.2 A Resolution
  JOURNAL   J.Mol.Biol. 232, 947 (1993)
REFERENCE   2  (residues 1 to 223)
  AUTHORS   Stubbs,M.T., Huber,R. and Bode,W.
  TITLE     Crystal Structures of Factor Xa Specific Inhibitors in Complex with
            Trypsin: Structural Grounds for Inhibition of Factor Xa and
            Selectivity Against Thrombin
  JOURNAL   FEBS Lett. 375, 103 (1995)
REFERENCE   3  (residues 1 to 223)
  AUTHORS   Stubbs,M.T. II.
  TITLE     Structural Aspects of Factor Xa Inhibition
  JOURNAL   Curr.Pharm.Des. 2, 543 (1996)
REFERENCE   4  (residues 1 to 223)
  AUTHORS   Van De Locht,A., Stubbs,M.T., Bode,W., Friedrich,T.,
            Bollschweiler,C., Hoffken,W. and Huber,R.
  TITLE     The Ornithodorin-Thrombin Crystal Structure, a Key to the Tap
            Enigma?
  JOURNAL   Embo J. 15, 6011 (1996)
REFERENCE   5  (residues 1 to 223)
  AUTHORS   Brandstetter,H., K&#xfc;hne,A., Bode,W., Huber,R., von der Saal,W.,
            Wirthensohn,K. and Engh,R.A.
  TITLE     X-ray structure of active site-inhibited clotting factor Xa.
            Implications for drug design and substrate recognition
  JOURNAL   J Biol Chem 271 (47), 29988-29992 (1996)
   PUBMED   8939944
REFERENCE   6  (residues 1 to 223)
  AUTHORS   Burgering,M.J., Orbons,L.P., van der Doelen,A., Mulders,J.,
            Theunissen,H.J., Grootenhuis,P.D., Bode,W., Huber,R. and
            Stubbs,M.T.
  TITLE     The second Kunitz domain of human tissue factor pathway inhibitor:
            cloning, structure determination and interaction with factor Xa
  JOURNAL   J Mol Biol 269 (3), 395-407 (1997)
   PUBMED   9199408
REFERENCE   7  (residues 1 to 223)
  AUTHORS   Stubbs,M.T., Morenweiser,R., St&#xfc;rzebecher,J., Bauer,M.,
            Bode,W., Huber,R., Piechottka,G.P., Matschiner,G., Sommerhoff,C.P.,
            Fritz,H. and Auerswald,E.A.
  TITLE     The three-dimensional structure of recombinant leech-derived
            tryptase inhibitor in complex with trypsin. Implications for the
            structure of human mast cell tryptase and its inhibition
  JOURNAL   J Biol Chem 272 (32), 19931-19937 (1997)
   PUBMED   9242660
REFERENCE   8  (residues 1 to 223)
  AUTHORS   Stubbs,M.T. and Huber,R.
  TITLE     Direct Submission
  JOURNAL   Submitted (21-JAN-1997)
COMMENT     COMPLEX OF THE SECOND KUNITZ DOMAIN OF TISSUE FACTOR PATHWAY
            INHIBITOR WITH PORCINE TRYPSIN.
FEATURES             Location/Qualifiers
     source          1..223
                     /organism="Sus scrofa"
                     /db_xref="taxon:9823"
     Region          1..219
                     /region_name="Tryp_SPc"
                     /note="Trypsin-like serine protease; Many of these are
                     synthesized as inactive precursor zymogens that are
                     cleaved during limited proteolysis to generate their
                     active forms. Alignment contains also inactive enzymes
                     that have substitutions of the catalytic triad...;
                     cd00190"
                     /db_xref="CDD:238113"
     Region          join(1..10,103..210)
                     /region_name="Domain 1"
                     /note="NCBI Domains"
     Site            1
                     /site_type="active"
                     /note="cleavage site [active]"
                     /db_xref="CDD:238113"
     SecStr          4..7
                     /sec_str_type="sheet"
                     /note="strand 1"
     Bond            bond(7,137)
                     /bond_type="disulfide"
     Region          join(11..102,211..223)
                     /region_name="Domain 2"
                     /note="NCBI Domains"
     SecStr          14..20
                     /sec_str_type="sheet"
                     /note="strand 2"
     SecStr          22..31
                     /sec_str_type="sheet"
                     /note="strand 3"
     Bond            bond(25,41)
                     /bond_type="disulfide"
     SecStr          33..38
                     /sec_str_type="sheet"
                     /note="strand 4"
     Site            order(40,84,177)
                     /site_type="active"
                     /db_xref="CDD:238113"
     SecStr          46..51
                     /sec_str_type="sheet"
                     /note="strand 5"
     Het             join(bond(52),bond(54),bond(57),bond(59),bond(62))
                     /heterogen="(CA,4239)"
     SecStr          62..67
                     /sec_str_type="sheet"
                     /note="strand 6"
     SecStr          68..73
                     /sec_str_type="sheet"
                     /note="strand 7"
     SecStr          75..79
                     /sec_str_type="sheet"
                     /note="strand 8"
     SecStr          80..83
                     /sec_str_type="sheet"
                     /note="strand 9"
     SecStr          85..90
                     /sec_str_type="sheet"
                     /note="strand 10"
     Bond            bond(109,210)
                     /bond_type="disulfide"
     SecStr          114..121
                     /sec_str_type="sheet"
                     /note="strand 11"
     Bond            bond(116,183)
                     /bond_type="disulfide"
     SecStr          123..126
                     /sec_str_type="sheet"
                     /note="strand 12"
     SecStr          128..131
                     /sec_str_type="sheet"
                     /note="strand 13"
     SecStr          135..142
                     /sec_str_type="sheet"
                     /note="strand 14"
     SecStr          145..152
                     /sec_str_type="helix"
                     /note="helix 1"
     Bond            bond(148,162)
                     /bond_type="disulfide"
     SecStr          159..164
                     /sec_str_type="sheet"
                     /note="strand 15"
     SecStr          166..169
                     /sec_str_type="sheet"
                     /note="strand 16"
     Site            order(171,192,194)
                     /site_type="other"
                     /note="substrate binding sites [chemical binding]"
                     /db_xref="CDD:238113"
     Bond            bond(173,197)
                     /bond_type="disulfide"
     SecStr          179..184
                     /sec_str_type="sheet"
                     /note="strand 17"
     SecStr          185..193
                     /sec_str_type="sheet"
                     /note="strand 18"
     SecStr          198..201
                     /sec_str_type="sheet"
                     /note="strand 19"
     SecStr          203..208
                     /sec_str_type="sheet"
                     /note="strand 20"
     SecStr          213..222
                     /sec_str_type="helix"
                     /note="helix 2"
ORIGIN      
        1 ivggytcaan sipyqvslns gshfcggsli nsqwvvsaah cyksriqvrl gehnidvleg
       61 neqfinaaki ithpnfngnt ldndimlikl sspatlnsrv atvslprsca aagteclisg
      121 wgntkssgss ypsllqclka pvlsdsscks sypgqitgnm icvgfleggk dscqgdsggp
      181 vvcngqlqgi vswgygcaqk nkpgvytkvc nyvnwiqqti aan
//

LOCUS       1TFX_B                   223 aa            linear   MAM 31-OCT-2024
DEFINITION  Chain B, TRYPSIN.
ACCESSION   1TFX_B
VERSION     1TFX_B
DBSOURCE    pdb: molecule 1TFX, chain B, release Oct 30, 2024;
            deposition: Jan 21, 1997;
            class: COMPLEX (SERINE PROTEASE/INHIBITOR);
            source: Mmdb_id: 7140, Pdb_id 1: 1TFX;
            Exp. method: X-ray Diffraction.
KEYWORDS    .
SOURCE      Sus scrofa (pig)
  ORGANISM  Sus scrofa
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Laurasiatheria; Artiodactyla; Suina; Suidae;
            Sus.
REFERENCE   1  (residues 1 to 223)
  AUTHORS   Padmanabhan,K., Padmanabhan,K.P., Tulinsky,A., Park,C.H., Bode,W.,
            Huber,R., Blankenship,D.T., Cardin,A.D. and Kisiel,W.
  TITLE     Structure of Human Des(1-45) Factor Xa at 2.2 A Resolution
  JOURNAL   J.Mol.Biol. 232, 947 (1993)
REFERENCE   2  (residues 1 to 223)
  AUTHORS   Stubbs,M.T., Huber,R. and Bode,W.
  TITLE     Crystal Structures of Factor Xa Specific Inhibitors in Complex with
            Trypsin: Structural Grounds for Inhibition of Factor Xa and
            Selectivity Against Thrombin
  JOURNAL   FEBS Lett. 375, 103 (1995)
REFERENCE   3  (residues 1 to 223)
  AUTHORS   Stubbs,M.T. II.
  TITLE     Structural Aspects of Factor Xa Inhibition
  JOURNAL   Curr.Pharm.Des. 2, 543 (1996)
REFERENCE   4  (residues 1 to 223)
  AUTHORS   Van De Locht,A., Stubbs,M.T., Bode,W., Friedrich,T.,
            Bollschweiler,C., Hoffken,W. and Huber,R.
  TITLE     The Ornithodorin-Thrombin Crystal Structure, a Key to the Tap
            Enigma?
  JOURNAL   Embo J. 15, 6011 (1996)
REFERENCE   5  (residues 1 to 223)
  AUTHORS   Brandstetter,H., K&#xfc;hne,A., Bode,W., Huber,R., von der Saal,W.,
            Wirthensohn,K. and Engh,R.A.
  TITLE     X-ray structure of active site-inhibited clotting factor Xa.
            Implications for drug design and substrate recognition
  JOURNAL   J Biol Chem 271 (47), 29988-29992 (1996)
   PUBMED   8939944
REFERENCE   6  (residues 1 to 223)
  AUTHORS   Burgering,M.J., Orbons,L.P., van der Doelen,A., Mulders,J.,
            Theunissen,H.J., Grootenhuis,P.D., Bode,W., Huber,R. and
            Stubbs,M.T.
  TITLE     The second Kunitz domain of human tissue factor pathway inhibitor:
            cloning, structure determination and interaction with factor Xa
  JOURNAL   J Mol Biol 269 (3), 395-407 (1997)
   PUBMED   9199408
REFERENCE   7  (residues 1 to 223)
  AUTHORS   Stubbs,M.T., Morenweiser,R., St&#xfc;rzebecher,J., Bauer,M.,
            Bode,W., Huber,R., Piechottka,G.P., Matschiner,G., Sommerhoff,C.P.,
            Fritz,H. and Auerswald,E.A.
  TITLE     The three-dimensional structure of recombinant leech-derived
            tryptase inhibitor in complex with trypsin. Implications for the
            structure of human mast cell tryptase and its inhibition
  JOURNAL   J Biol Chem 272 (32), 19931-19937 (1997)
   PUBMED   9242660
REFERENCE   8  (residues 1 to 223)
  AUTHORS   Stubbs,M.T. and Huber,R.
  TITLE     Direct Submission
  JOURNAL   Submitted (21-JAN-1997)
COMMENT     COMPLEX OF THE SECOND KUNITZ DOMAIN OF TISSUE FACTOR PATHWAY
            INHIBITOR WITH PORCINE TRYPSIN.
FEATURES             Location/Qualifiers
     source          1..223
                     /organism="Sus scrofa"
                     /db_xref="taxon:9823"
     Region          1..219
                     /region_name="Tryp_SPc"
                     /note="Trypsin-like serine protease; Many of these are
                     synthesized as inactive precursor zymogens that are
                     cleaved during limited proteolysis to generate their
                     active forms. Alignment contains also inactive enzymes
                     that have substitutions of the catalytic triad...;
                     cd00190"
                     /db_xref="CDD:238113"
     Site            1
                     /site_type="active"
                     /note="cleavage site [active]"
                     /db_xref="CDD:238113"
     Bond            bond(7,137)
                     /bond_type="disulfide"
     SecStr          14..20
                     /sec_str_type="sheet"
                     /note="strand 21"
     SecStr          22..31
                     /sec_str_type="sheet"
                     /note="strand 22"
     SecStr          33..38
                     /sec_str_type="sheet"
                     /note="strand 23"
     Site            order(40,84,177)
                     /site_type="active"
                     /db_xref="CDD:238113"
     SecStr          46..51
                     /sec_str_type="sheet"
                     /note="strand 24"
     Het             join(bond(52),bond(54),bond(57),bond(59),bond(62))
                     /heterogen="(CA,4240)"
     SecStr          62..67
                     /sec_str_type="sheet"
                     /note="strand 25"
     SecStr          68..73
                     /sec_str_type="sheet"
                     /note="strand 26"
     SecStr          75..79
                     /sec_str_type="sheet"
                     /note="strand 27"
     SecStr          80..83
                     /sec_str_type="sheet"
                     /note="strand 28"
     SecStr          85..90
                     /sec_str_type="sheet"
                     /note="strand 29"
     Bond            bond(109,210)
                     /bond_type="disulfide"
     SecStr          114..121
                     /sec_str_type="sheet"
                     /note="strand 30"
     Bond            bond(116,183)
                     /bond_type="disulfide"
     SecStr          123..126
                     /sec_str_type="sheet"
                     /note="strand 31"
     SecStr          128..131
                     /sec_str_type="sheet"
                     /note="strand 32"
     SecStr          135..142
                     /sec_str_type="sheet"
                     /note="strand 33"
     SecStr          145..152
                     /sec_str_type="helix"
                     /note="helix 3"
     Bond            bond(148,162)
                     /bond_type="disulfide"
     SecStr          159..164
                     /sec_str_type="sheet"
                     /note="strand 34"
     SecStr          166..169
                     /sec_str_type="sheet"
                     /note="strand 35"
     Site            order(171,192,194)
                     /site_type="other"
                     /note="substrate binding sites [chemical binding]"
                     /db_xref="CDD:238113"
     Bond            bond(173,197)
                     /bond_type="disulfide"
     SecStr          177..184
                     /sec_str_type="sheet"
                     /note="strand 36"
     SecStr          185..193
                     /sec_str_type="sheet"
                     /note="strand 37"
     SecStr          198..201
                     /sec_str_type="sheet"
                     /note="strand 38"
     SecStr          203..208
                     /sec_str_type="sheet"
                     /note="strand 39"
     SecStr          213..222
                     /sec_str_type="helix"
                     /note="helix 4"
ORIGIN      
        1 ivggytcaan sipyqvslns gshfcggsli nsqwvvsaah cyksriqvrl gehnidvleg
       61 neqfinaaki ithpnfngnt ldndimlikl sspatlnsrv atvslprsca aagteclisg
      121 wgntkssgss ypsllqclka pvlsdsscks sypgqitgnm icvgfleggk dscqgdsggp
      181 vvcngqlqgi vswgygcaqk nkpgvytkvc nyvnwiqqti aan
//

LOCUS       1TFX_C                    58 aa            linear   PRI 31-OCT-2024
DEFINITION  Chain C, TISSUE FACTOR PATHWAY INHIBITOR.
ACCESSION   1TFX_C
VERSION     1TFX_C
DBSOURCE    pdb: molecule 1TFX, chain C, release Oct 30, 2024;
            deposition: Jan 21, 1997;
            class: COMPLEX (SERINE PROTEASE/INHIBITOR);
            source: Mmdb_id: 7140, Pdb_id 1: 1TFX;
            Exp. method: X-ray Diffraction.
KEYWORDS    .
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 58)
  AUTHORS   Padmanabhan,K., Padmanabhan,K.P., Tulinsky,A., Park,C.H., Bode,W.,
            Huber,R., Blankenship,D.T., Cardin,A.D. and Kisiel,W.
  TITLE     Structure of Human Des(1-45) Factor Xa at 2.2 A Resolution
  JOURNAL   J.Mol.Biol. 232, 947 (1993)
REFERENCE   2  (residues 1 to 58)
  AUTHORS   Stubbs,M.T., Huber,R. and Bode,W.
  TITLE     Crystal Structures of Factor Xa Specific Inhibitors in Complex with
            Trypsin: Structural Grounds for Inhibition of Factor Xa and
            Selectivity Against Thrombin
  JOURNAL   FEBS Lett. 375, 103 (1995)
REFERENCE   3  (residues 1 to 58)
  AUTHORS   Stubbs,M.T. II.
  TITLE     Structural Aspects of Factor Xa Inhibition
  JOURNAL   Curr.Pharm.Des. 2, 543 (1996)
REFERENCE   4  (residues 1 to 58)
  AUTHORS   Van De Locht,A., Stubbs,M.T., Bode,W., Friedrich,T.,
            Bollschweiler,C., Hoffken,W. and Huber,R.
  TITLE     The Ornithodorin-Thrombin Crystal Structure, a Key to the Tap
            Enigma?
  JOURNAL   Embo J. 15, 6011 (1996)
REFERENCE   5  (residues 1 to 58)
  AUTHORS   Brandstetter,H., K&#xfc;hne,A., Bode,W., Huber,R., von der Saal,W.,
            Wirthensohn,K. and Engh,R.A.
  TITLE     X-ray structure of active site-inhibited clotting factor Xa.
            Implications for drug design and substrate recognition
  JOURNAL   J Biol Chem 271 (47), 29988-29992 (1996)
   PUBMED   8939944
REFERENCE   6  (residues 1 to 58)
  AUTHORS   Burgering,M.J., Orbons,L.P., van der Doelen,A., Mulders,J.,
            Theunissen,H.J., Grootenhuis,P.D., Bode,W., Huber,R. and
            Stubbs,M.T.
  TITLE     The second Kunitz domain of human tissue factor pathway inhibitor:
            cloning, structure determination and interaction with factor Xa
  JOURNAL   J Mol Biol 269 (3), 395-407 (1997)
   PUBMED   9199408
REFERENCE   7  (residues 1 to 58)
  AUTHORS   Stubbs,M.T., Morenweiser,R., St&#xfc;rzebecher,J., Bauer,M.,
            Bode,W., Huber,R., Piechottka,G.P., Matschiner,G., Sommerhoff,C.P.,
            Fritz,H. and Auerswald,E.A.
  TITLE     The three-dimensional structure of recombinant leech-derived
            tryptase inhibitor in complex with trypsin. Implications for the
            structure of human mast cell tryptase and its inhibition
  JOURNAL   J Biol Chem 272 (32), 19931-19937 (1997)
   PUBMED   9242660
REFERENCE   8  (residues 1 to 58)
  AUTHORS   Stubbs,M.T. and Huber,R.
  TITLE     Direct Submission
  JOURNAL   Submitted (21-JAN-1997)
COMMENT     COMPLEX OF THE SECOND KUNITZ DOMAIN OF TISSUE FACTOR PATHWAY
            INHIBITOR WITH PORCINE TRYPSIN.
FEATURES             Location/Qualifiers
     source          1..58
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
     Region          1..56
                     /region_name="Kunitz_TFPI1_2-like"
                     /note="Kunitz protease inhibitor (KPI) domain 2 (KPI-2 or
                     K2) of tissue factor pathway inhibitor (TFPI); cd22614"
                     /db_xref="CDD:438657"
     Bond            bond(5,55)
                     /bond_type="disulfide"
     Site            order(13..17,36,38..39)
                     /site_type="other"
                     /note="serine protease binding site [polypeptide binding]"
                     /db_xref="CDD:438657"
     Bond            bond(14,38)
                     /bond_type="disulfide"
     SecStr          16..26
                     /sec_str_type="sheet"
                     /note="strand 40"
     SecStr          27..36
                     /sec_str_type="sheet"
                     /note="strand 41"
     Bond            bond(30,51)
                     /bond_type="disulfide"
     SecStr          47..55
                     /sec_str_type="helix"
                     /note="helix 5"
ORIGIN      
        1 kpdfcfleed pgicrgyitr yfynnqtkqc erfkyggclg nmnnfetlee cknicedg
//

LOCUS       1TFX_D                    58 aa            linear   PRI 31-OCT-2024
DEFINITION  Chain D, TISSUE FACTOR PATHWAY INHIBITOR.
ACCESSION   1TFX_D
VERSION     1TFX_D
DBSOURCE    pdb: molecule 1TFX, chain D, release Oct 30, 2024;
            deposition: Jan 21, 1997;
            class: COMPLEX (SERINE PROTEASE/INHIBITOR);
            source: Mmdb_id: 7140, Pdb_id 1: 1TFX;
            Exp. method: X-ray Diffraction.
KEYWORDS    .
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 58)
  AUTHORS   Padmanabhan,K., Padmanabhan,K.P., Tulinsky,A., Park,C.H., Bode,W.,
            Huber,R., Blankenship,D.T., Cardin,A.D. and Kisiel,W.
  TITLE     Structure of Human Des(1-45) Factor Xa at 2.2 A Resolution
  JOURNAL   J.Mol.Biol. 232, 947 (1993)
REFERENCE   2  (residues 1 to 58)
  AUTHORS   Stubbs,M.T., Huber,R. and Bode,W.
  TITLE     Crystal Structures of Factor Xa Specific Inhibitors in Complex with
            Trypsin: Structural Grounds for Inhibition of Factor Xa and
            Selectivity Against Thrombin
  JOURNAL   FEBS Lett. 375, 103 (1995)
REFERENCE   3  (residues 1 to 58)
  AUTHORS   Stubbs,M.T. II.
  TITLE     Structural Aspects of Factor Xa Inhibition
  JOURNAL   Curr.Pharm.Des. 2, 543 (1996)
REFERENCE   4  (residues 1 to 58)
  AUTHORS   Van De Locht,A., Stubbs,M.T., Bode,W., Friedrich,T.,
            Bollschweiler,C., Hoffken,W. and Huber,R.
  TITLE     The Ornithodorin-Thrombin Crystal Structure, a Key to the Tap
            Enigma?
  JOURNAL   Embo J. 15, 6011 (1996)
REFERENCE   5  (residues 1 to 58)
  AUTHORS   Brandstetter,H., K&#xfc;hne,A., Bode,W., Huber,R., von der Saal,W.,
            Wirthensohn,K. and Engh,R.A.
  TITLE     X-ray structure of active site-inhibited clotting factor Xa.
            Implications for drug design and substrate recognition
  JOURNAL   J Biol Chem 271 (47), 29988-29992 (1996)
   PUBMED   8939944
REFERENCE   6  (residues 1 to 58)
  AUTHORS   Burgering,M.J., Orbons,L.P., van der Doelen,A., Mulders,J.,
            Theunissen,H.J., Grootenhuis,P.D., Bode,W., Huber,R. and
            Stubbs,M.T.
  TITLE     The second Kunitz domain of human tissue factor pathway inhibitor:
            cloning, structure determination and interaction with factor Xa
  JOURNAL   J Mol Biol 269 (3), 395-407 (1997)
   PUBMED   9199408
REFERENCE   7  (residues 1 to 58)
  AUTHORS   Stubbs,M.T., Morenweiser,R., St&#xfc;rzebecher,J., Bauer,M.,
            Bode,W., Huber,R., Piechottka,G.P., Matschiner,G., Sommerhoff,C.P.,
            Fritz,H. and Auerswald,E.A.
  TITLE     The three-dimensional structure of recombinant leech-derived
            tryptase inhibitor in complex with trypsin. Implications for the
            structure of human mast cell tryptase and its inhibition
  JOURNAL   J Biol Chem 272 (32), 19931-19937 (1997)
   PUBMED   9242660
REFERENCE   8  (residues 1 to 58)
  AUTHORS   Stubbs,M.T. and Huber,R.
  TITLE     Direct Submission
  JOURNAL   Submitted (21-JAN-1997)
COMMENT     COMPLEX OF THE SECOND KUNITZ DOMAIN OF TISSUE FACTOR PATHWAY
            INHIBITOR WITH PORCINE TRYPSIN.
FEATURES             Location/Qualifiers
     source          1..58
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
     Region          1..56
                     /region_name="Kunitz_TFPI1_2-like"
                     /note="Kunitz protease inhibitor (KPI) domain 2 (KPI-2 or
                     K2) of tissue factor pathway inhibitor (TFPI); cd22614"
                     /db_xref="CDD:438657"
     Site            order(13..17,36,38..39)
                     /site_type="other"
                     /note="serine protease binding site [polypeptide binding]"
                     /db_xref="CDD:438657"
     Bond            bond(14,38)
                     /bond_type="disulfide"
     SecStr          16..25
                     /sec_str_type="sheet"
                     /note="strand 42"
     SecStr          28..37
                     /sec_str_type="sheet"
                     /note="strand 43"
     SecStr          47..55
                     /sec_str_type="helix"
                     /note="helix 6"
ORIGIN      
        1 kpdfcfleed pgicrgyitr yfynnqtkqc erfkyggclg nmnnfetlee cknicedg
//

